Skip to main content
Tyvin Rich, MD, Radiation Oncology, Charlottesville, VA

TyvinA.RichMD

Radiation Oncology Charlottesville, VA

Professor of Radiation Oncology, University VA School of Medicine

Dr. Rich is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rich's full profile

Already have an account?

  • Office

    UVA Hospital West
    Hospital Drive 3RD floor
    Charlottesville, VA 22908
    Phone+1 434-924-0473
    Fax+1 434-982-3262

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 1978 - 1979
  • Massachusetts General Hospital/Harvard Medical School
    Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiology-Diagnostic, 1975 - 1978
  • District of Columbia General Hospital
    District of Columbia General HospitalInternship, Internal Medicine, 1973 - 1974
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 1973

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 1995 - 2026
  • TX State Medical License
    TX State Medical License 1984 - 1996
  • American Board of Radiology Therapeutic Radiology

Awards, Honors, & Recognition

  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
    Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with GlioblastomaAugust 14th, 2024

Professional Memberships